Adicet Bio, Inc. — Director's Dealing 2024

Aug 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2024-08-21

Reporting Person: Peng Katie (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-21	Stock Option (Right to Buy)	$2.14	D	70200	Disposed	2033-07-09	Common Stock (70200)	Direct
2024-08-21	Stock Option (Right to Buy)	$3.38	A	70200	Acquired	2033-07-09	Common Stock (70200)	Direct

Footnotes

F1: Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

F2: The shares subject to this option shall vest in thirty-six (36) equal monthly installments commencing on July 10, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors as of the applicable vesting date.